Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting, 3227-3228 [2025-00597]

Download as PDF 3227 Federal Register / Vol. 90, No. 8 / Tuesday, January 14, 2025 / Notices TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1 Number of respondents Information collection activity Total annual responses Average burden per response Total hours Submission of Generic Drug User Fee Cover Sheet .......... 500 7.616 3,808 0.5 (30 minutes) 1,904 Submission of Controlled Correspondence as Discussed in Agency Topic-Specific Guidance Documents .............. 400 12.5 5000 5 25,000 Total .............................................................................. ........................ ........................ 8,808 ........................ 26,904 1 There are no capital costs or operating and maintenance costs associated with this collection of information. Our estimated is based on available Agency data. Our burden estimate reflects an overall increase attributable to the inclusion of controlled correspondence and new generic drug product CPA requests. Dated: January 7, 2025. P. Ritu Nalubola, Associate Commissioner for Policy. [FR Doc. 2025–00564 Filed 1–13–25; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Physician-Focused Payment Model Technical Advisory Committee; Meetings ACTION: Notice of meetings. This notice announces the 2025 meetings of the Physician-Focused Payment Model Technical Advisory Committee (PTAC). These meetings include deliberation and voting on proposals for physician-focused payment models (PFPMs) submitted by individuals and stakeholder entities and may include discussions on topics related to current or previously submitted PFPMs. All meetings are open to the public. DATES: The 2025 PTAC meetings will occur on the following dates: D Monday–Tuesday, March 3–4, 2025, from 9 a.m. to 5 p.m. ET D Tuesday–Wednesday, June 3–4, 2025, from 9 a.m. to 5 p.m. ET D Monday–Tuesday, September 8–9, 2025, from 9 a.m. to 5 p.m. ET D Tuesday–Wednesday, December 9–10, 2025, from 9 a.m. to 5 p.m. ET Please note that times are subject to change. If the times change, the ASPE PTAC website will be updated (https:// aspe.hhs.gov/ptac-physician-focusedpayment-model-technical-advisorycommittee) and registrants will be notified directly via email. ADDRESSES: All PTAC meetings will be held virtually and/or in the Great Hall SUMMARY: khammond on DSK9W7S144PROD with NOTICES Number of responses per respondent VerDate Sep<11>2014 22:42 Jan 13, 2025 Jkt 265001 of the Hubert H. Humphrey Building, 200 Independence Avenue SW, Washington, DC, 20201. FOR FURTHER INFORMATION CONTACT: Lisa Shats, Designated Federal Officer at Lisa.Shats@hhs.gov (202) 875–0938. SUPPLEMENTARY INFORMATION: Agenda and Comments. PTAC will hear presentations on proposed PFPMs that have been submitted by individuals and stakeholder entities and/or discussion on topics related to current or previously submitted PFPMs. Regarding proposed PFPMs, following each presentation, PTAC will deliberate on the proposed PFPM. If PTAC completes its deliberation, PTAC will vote on the extent to which the proposed PFPM meets criteria established by the Secretary of Health and Human Services and on an overall recommendation to the Secretary (if applicable). Time will be allocated for public comments. The agenda and other documents will be posted on the PTAC section of the ASPE website, https:// aspe.hhs.gov/ptac-physician-focusedpayment-model-technical-advisorycommittee, prior to the meeting. The agenda is subject to change. If the agenda does change, registrants will be notified directly via email, the website will be updated, and notification will be sent out through the PTAC email listserv (https://list.nih.gov/cgi-bin/ wa.exe?A0=PTAC to subscribe). Meeting Attendance. These meetings are open to the public and may be hosted in-person or virtually. We intend that in-person meetings will be held in the Great Hall of the Hubert H. Humphrey Building. The public may attend in person, when feasible, virtually, or view the meeting via livestream at www.hhs.gov/live. Information about how to access the meeting virtually or via livestream will be sent to registrants prior to the meeting; and a telephone number will be sent to registrants participating via the dial-in only option prior to the meeting. Space may be limited, and registration is preferred. When PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 registration opens, a link to the registration page will be available at https://aspe.hhs.gov/collaborationscommittees-advisory-groups/ptac/ptacmeetings prior to the meeting. Registrants will receive a confirmation email shortly after completing the registration process. Special Accommodations. If sign language interpretation or other reasonable accommodation for a disability is needed, please contact PTAC@hhs.gov, no later than two weeks prior to the scheduled meeting. Authority. 42 U.S.C. 1395(ee); section 101(e)(1) of the Medicare Access and CHIP Reauthorization Act of 2015; section 51003(b) of the Bipartisan Budget Act of 2018. PTAC is governed by provisions of the Federal Advisory Committee Act, as amended (5 U.S.C app.), which sets forth standards for the formation and use of federal advisory committees. Dated: January 3, 2025. Tisamarie B. Sherry, Deputy Assistant Secretary for Behavioral Health, Disability and Aging Policy, Performing the Delegable Duties of the Assistant Secretary for Planning and Evaluation. [FR Doc. 2025–00612 Filed 1–13–25; 8:45 am] BILLING CODE 4150–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and E:\FR\FM\14JAN1.SGM 14JAN1 3228 Federal Register / Vol. 90, No. 8 / Tuesday, January 14, 2025 / Notices the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Eunice Kennedy Shriver National Institute of Child Health and Human Development Special Emphasis Panel; Multicenter Clinical Trials; Leveraging Network (U01). Date: March 7, 2025. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Address: Eunice Kennedy Shriver National Institute of Child Health and Human Development, 6710 B Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Vera A. Cherkasova, Ph.D., Scientific Review Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, 6710B Rockledge Drive, Room 2137B, Bethesda, MD 20892, (240) 478–4580, vera.cherkasova@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: January 8, 2025. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2025–00597 Filed 1–13–25; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health khammond on DSK9W7S144PROD with NOTICES Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. VerDate Sep<11>2014 22:42 Jan 13, 2025 Jkt 265001 Name of Committee: Eunice Kennedy Shriver National Institute of Child Health and Human Development Special Emphasis Panel; the Road to Prevention of Stillbirth— Data Coordinating Center (UM2) Companion. Date: March 28, 2025. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Address: Eunice Kennedy Shriver National Institute of Child Health and Human Development, 6710 B Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Luis E. Dettin, Ph.D., Scientific Review Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH 6710B, Rockledge Drive, Rm. 2131B, Bethesda, MD 20892, (301) 827–8231, luis_dettin@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: January 8, 2025. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2025–00605 Filed 1–13–25; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Eunice Kennedy Shriver National Institute of Child Health and Human Development Special Emphasis Panel; the Road to Prevention of Stillbirth— Clinical Research Center (UG1). Date: March 24, 2025. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Address: Eunice Kennedy Shriver National Institute of Child Health and Human PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 Development, 6710 B Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting: Contact Person: Luis E. Dettin, Ph.D., Scientific Review Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH 6710B, Rockledge Drive, Rm. 2131B Bethesda, MD 20892, (301) 827–8231, luis_dettin@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: January 8, 2025. Lauren A. Fleck, Program Analyst,Office of Federal Advisory Committee Policy. [FR Doc. 2025–00607 Filed 1–13–25; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Eunice Kennedy Shriver National Institute of Child Health and Human Development Initial Review Group, Population Sciences Study Section. Date: March 6, 2025. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Address: Eunice Kennedy Shriver National Institute of Child Health and Human Development, 6710 B Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Christiane M. Robbins, Scientific Review Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, 6710B Rockledge Drive, Rm 2121B, Bethesda, MD 20817, 301–451–4989, crobbins@ mail.nih.gov. E:\FR\FM\14JAN1.SGM 14JAN1

Agencies

[Federal Register Volume 90, Number 8 (Tuesday, January 14, 2025)]
[Notices]
[Pages 3227-3228]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-00597]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health & Human 
Development; Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and

[[Page 3228]]

the discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: Eunice Kennedy Shriver National Institute of 
Child Health and Human Development Special Emphasis Panel; 
Multicenter Clinical Trials; Leveraging Network (U01).
    Date: March 7, 2025.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: Eunice Kennedy Shriver National Institute of Child 
Health and Human Development, 6710 B Rockledge Drive, Bethesda, MD 
20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Vera A. Cherkasova, Ph.D., Scientific Review 
Branch, Eunice Kennedy Shriver National Institute of Child Health 
and Human Development, NIH, 6710B Rockledge Drive, Room 2137B, 
Bethesda, MD 20892, (240) 478-4580, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: January 8, 2025.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2025-00597 Filed 1-13-25; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.